BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Yang J, Shen H, Zhang X, Wang H, Wu G, Qi Y, Wang L, Xu W. Muc5ac Production Inhibited by Decreased lncRNA H19 via PI3K/Akt/NF-kB in Asthma. J Asthma Allergy 2021;14:1033-43. [PMID: 34421304 DOI: 10.2147/JAA.S316250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Bai J, Wang W. CST1 promotes the proliferation and migration of PDGF‐BB ‐treated airway smooth muscle cells via the PI3K / AKT signaling pathway. The Kaohsiung J of Med Scie 2022. [DOI: 10.1002/kjm2.12619] [Reference Citation Analysis]
2 Cheng S, Tang Q, Xie S, Wen S, Zhang H, Xie Z, Jiang W, Shadab M. The Role of Noncoding RNA in Airway Allergic Diseases through Regulation of T Cell Subsets. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/6125698] [Reference Citation Analysis]
3 Xie J, Hu Y, Sun D, Liu C, Li Z, Zhu J. Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases. Front Pharmacol 2022;13:978151. [DOI: 10.3389/fphar.2022.978151] [Reference Citation Analysis]
4 Li M, Zhong X, Xu WT. Substance P promotes the progression of bronchial asthma through activating the PI3K/AKT/NF-κB pathway mediated cellular inflammation and pyroptotic cell death in bronchial epithelial cells. Cell Cycle 2022;:1-13. [PMID: 35726575 DOI: 10.1080/15384101.2022.2092166] [Reference Citation Analysis]
5 Chen F, Du L, Zeng Z, Huang X, Xu C, Tan W, Xie C, Liang Y, Guo Y. PTPRH Alleviates Airway Obstruction and Th2 Inflammation in Asthma as a Protective Factor. JAA 2022;Volume 15:133-44. [DOI: 10.2147/jaa.s340059] [Reference Citation Analysis]